Terumo Blood and Cell Technologies' Peer-Reviewed Publication Shows Hollow Fiber-Based Bioreactors Can Produce 8x Viral Vector-Producing Cells in Four Days
Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, announced the publication of a peer-reviewed manuscript regarding a new protocol for automated expansion of HEK293T cells that are used to produce the viral vectors powering cell and gene therapies. The accepted manuscript, published ...
United States Mindym Miller Dalip Sethi Nathand Frank Terumo Corporation International Society For Cell Gene Therapy
Source: pharmiweb.com